PPARGC1A and colorectal carcinoma: Interestingly, there are two diametrically opposite conclusions according to the reports of colon cancer: some studies have shown that the upregulation of PPARGC1A will increase the risk of CRC [46, 47], while others have shown that underexpression increases the risk of CRC [48, 49].